Comparative study of 18F-DCFPyL PET/CT and 99mTc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer

Comparative study of 18F-DCFPyL PET/CT and 99mTc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer

PurposeThis study aimed to compare the diagnostic efficiency of 18F-DCFPyL PET/CT imaging and 99mTc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer.MethodsA retrospective analysis was conducted on 31 patients with confirmed prostate cancer between September 2020 and...

Full description

Bibliographic Details
Main Authors:	Xiongjian Hu, Yiming Cao, Bin Ji, Min Zhao, Qiang Wen, Bin Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Medicine
Subjects:	18F-DCFPyL bone scan prostate-specific membrane antigen bone metastasis prostate cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1201977/full

Similar Items

18F-DCFPyL PET/CT in primary staging of prostate cancer
by: Maurits Wondergem, et al.
Published: (2018-10-01)

Evaluation of 18F-DCFPyL PSMA PET/CT for Prostate Cancer: A Meta-Analysis
by: Ke-Hao Pan, et al.
Published: (2021-02-01)

Prostate-specific membrane antigen PET versus [99mTc]Tc-MDP bone scan for diagnosing bone metastasis in prostate cancer: a head-to-head comparative meta-analysis
by: Yiming Wang, et al.
Published: (2024-09-01)

A Pilot Study of 18F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions
by: Yachao Liu, et al.
Published: (2021-03-01)

Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients
by: Yang Fu, et al.
Published: (2024-07-01)

Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of Biochemically Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis
by: Jiale Sun, et al.
Published: (2021-04-01)

Effect of 18F-DCFPyL PET on changes in management of patients with prostate cancer: a systematic review and meta-analysis
by: Hui Wang, et al.
Published: (2024-04-01)

Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
by: Gonçalo Ferreira, et al.
Published: (2019-05-01)

Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial
by: Shaoxi Niu, et al.
Published: (2025-01-01)

Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
by: Dae-Myoung Yang, et al.
Published: (2021-10-01)

18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
by: Ur Metser, et al.
Published: (2022-10-01)

Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on <sup>18</sup>F-DCFPyL PET/CT Scans
by: Tushar Garg, et al.
Published: (2022-10-01)

Quantitative [99mTc]Tc-MDP SPECT/CT correlated with [18F]NaF PET/CT for bone metastases in patients with prostate cancer
by: Kenichi Tanaka, et al.
Published: (2022-12-01)

Salivary excretion of systemically injected [18F]DCFPyL in prostate cancer patients undergoing PSMA scans
by: Bruna Fernandes, et al.
Published: (2024-04-01)

<sup>18</sup>F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
by: Ur Metser, et al.
Published: (2021-08-01)

The diagnostic performance of 18F-DCFPyL PET in patients with suspected prostate cancer: A systemic review and meta-analysis
by: Wenyang Pang, et al.
Published: (2023-03-01)

Intra-patient comparison of physiologic 68Ga-PSMA-11 and 18F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay
by: Medhat M. Osman, et al.
Published: (2021-04-01)

A case of accidental local pulmonary 99mTc‐MDP uptake on bone SPECT/CT
by: Yao Chen, et al.
Published: (2022-12-01)

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
by: Theresa Jung, et al.
Published: (2025-01-01)

Quantitative Analysis of 99mTc-MDP SPECT-CT Data in Diagnosing Bone Metastases in Breast Cancer Patients
by: Nora Almuqbil, et al.
Published: (2024-06-01)

Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
by: Lena Thomas, et al.
Published: (2017-07-01)

Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection
by: Surekha Yadav, et al.
Published: (2024-06-01)

Sinus Tarsi Syndrome: Diagnosed on 99m-Tc MDP Bone SPECT/CT
by: Abhishek Mahato, et al.
Published: (2020-07-01)

Head-to-Head Comparison of [<sup>18</sup>F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [<sup>18</sup>F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer
by: Laura García-Zoghby, et al.
Published: (2023-06-01)

The one-in-all diagnostic value of 99mTc-MDP bone scan combining with single-photon emission tomography (SPECT)/CT imaging in spinal osteoblastoma
by: Wenhui Ma, et al.
Published: (2020-05-01)

Accurate characterization of 99mTc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT/CT
by: Linqi Zhang, et al.
Published: (2019-05-01)

Higher Preoperative Maximum Standardised Uptake Values (SUV<sub>max</sub>) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]DCFPyL Positron Emission Tomography/Computed Tomography
by: Katelijne C. C. de Bie, et al.
Published: (2023-07-01)

Standardized uptake values of 99mTc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions
by: Na Qi, et al.
Published: (2021-02-01)

PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
by: Ismail MS, et al.
Published: (2023-12-01)

Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
by: Ana Rodríguez-Pajuelo, et al.
Published: (2025-02-01)

Delayed epiphyseal closure in an adult with panhypopituitarism detected by 99mTc‐MDP bone SPECT/CT
by: Yu Ning, et al.
Published: (2023-07-01)

Erdheim-Chester disease detected with 99MTC MDP bone SPECT/CT
by: G Ceulemans, et al.
Published: (2012-07-01)

Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
by: Qi Wang, et al.
Published: (2024-08-01)

Incidentally detected cardiac amyloidosis on 99mTc-MDP bone scintigraphy
by: Ahmed Fathala, MD
Published: (2020-06-01)

Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases
by: Flavian Tabotta, et al.
Published: (2019-12-01)

Temporal evolution of postsurgical bone repair in a rabbit model: A [99mTc]Tc-MDP scintigraphic study
by: A. Yoneda, et al.
Published: (2024-03-01)

Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer.
by: Batool Albalooshi, et al.
Published: (2020-01-01)

Characteristics of 99mTc-MDP Whole-body Bone Scintigraphy in Erdheim-Chester Disease
by: MA Yanru, et al.
Published: (2023-07-01)

Clinical value of Tc-99m MDP SPECT/CT bone imaging for early diagnosis of Relapsing Polychondritis: a report of 5 cases
by: Zilin Wang, et al.
Published: (2024-08-01)

The role of 99mTc-DPD bone SPECT/CT in the management of growth disturbance of the long bones in pediatric patients: a retrospective observational study
by: Chang Ho Shin, et al.
Published: (2023-08-01)